Viartril-S Special Precautions

In asthmatic patients, the product should be used with caution as these patients could be more susceptible to develop an allergic reaction to glucosamine with a possible exacerbation of their symptoms.
This medicinal product contains sodium which should be taken into consideration by patients on a controlled sodium diet.
No special studies were performed in patients with renal or hepatic insufficiency. The toxicological and pharmacokinetic profile of the product does not indicate limitations for these patients (capsule). However, the administration of this product to patients with severe hepatic or renal insufficiency should be under medical supervision.
Caution is advised in treatment of patients with impaired glucose tolerance. Closer monitoring of blood sugar levels may be necessary in diabetics (capsule) at the beginning of treatment.
Glucosamine should not be used in children and adolescents under the age of 18 since safety and efficacy have not been established.
The presence of other joint disease which would require alternative treatment should be excluded.
Effects on ability to drive and use machines: No studies on the effects on the ability to drive and use machines have been performed. No important effects on the CNS or motor system are known that might impair the ability to drive or use machines. However, caution is recommended if headache, somnolence, tiredness, dizziness or visual disturbances are experienced.
Powder for oral solution: Excipients: This medicinal product contains aspartame, a source of phenylalanine. It may be harmful if the patient has phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
This medicinal product contains sorbitol, a source of fructose. Patients with hereditary fructose intolerance (HFI) should not take/be given this medicine.